Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
by
Arneson, Laura C
, Carroll, Kristen J
, Ruderman, Eric M
in
acalabrutinib
/ Adalimumab
/ Analysis
/ Animal models
/ Arthritis
/ Autoimmune diseases
/ B cells
/ Binding sites
/ Blood cancer
/ Bruton's tyrosine kinase
/ Brutonâs tyrosine kinase
/ Cell activation
/ Cell growth
/ Clinical trials
/ Cytokines
/ Disease
/ Drug development
/ Drug dosages
/ Drug therapy
/ evobrutinib
/ fenebrutinib
/ Immunosuppressive agents
/ Kinases
/ Medical research
/ Medicine, Experimental
/ Metabolism
/ Phenols
/ Proteins
/ Receptor mechanisms
/ Review
/ Rheumatoid arthritis
/ Rheumatoid factor
/ spebrutinib
/ Tyrosine
/ Tyrosine kinase inhibitors
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
by
Arneson, Laura C
, Carroll, Kristen J
, Ruderman, Eric M
in
acalabrutinib
/ Adalimumab
/ Analysis
/ Animal models
/ Arthritis
/ Autoimmune diseases
/ B cells
/ Binding sites
/ Blood cancer
/ Bruton's tyrosine kinase
/ Brutonâs tyrosine kinase
/ Cell activation
/ Cell growth
/ Clinical trials
/ Cytokines
/ Disease
/ Drug development
/ Drug dosages
/ Drug therapy
/ evobrutinib
/ fenebrutinib
/ Immunosuppressive agents
/ Kinases
/ Medical research
/ Medicine, Experimental
/ Metabolism
/ Phenols
/ Proteins
/ Receptor mechanisms
/ Review
/ Rheumatoid arthritis
/ Rheumatoid factor
/ spebrutinib
/ Tyrosine
/ Tyrosine kinase inhibitors
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
by
Arneson, Laura C
, Carroll, Kristen J
, Ruderman, Eric M
in
acalabrutinib
/ Adalimumab
/ Analysis
/ Animal models
/ Arthritis
/ Autoimmune diseases
/ B cells
/ Binding sites
/ Blood cancer
/ Bruton's tyrosine kinase
/ Brutonâs tyrosine kinase
/ Cell activation
/ Cell growth
/ Clinical trials
/ Cytokines
/ Disease
/ Drug development
/ Drug dosages
/ Drug therapy
/ evobrutinib
/ fenebrutinib
/ Immunosuppressive agents
/ Kinases
/ Medical research
/ Medicine, Experimental
/ Metabolism
/ Phenols
/ Proteins
/ Receptor mechanisms
/ Review
/ Rheumatoid arthritis
/ Rheumatoid factor
/ spebrutinib
/ Tyrosine
/ Tyrosine kinase inhibitors
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
Journal Article
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Bruton's tyrosine kinase (BTK) inhibitors are an emerging class of drugs that inhibit B cell receptor activation, FC-[gamma] receptor signaling, and osteoclast proliferation. Following on approval for treatment of hematologic malignancies, BTK inhibitors are now under investigation to treat a number of different autoimmune diseases, including rheumatoid arthritis (RA). While the results of BTK inhibitors in RA animal models have been promising, the ensuing human clinical trial outcomes have been rather equivocal. This review will outline the mechanisms of BTK inhibition and its potential impact on immune mediated disease, the types of BTK inhibitors being studied for RA, the findings from both preclinical and clinical trials of BTK inhibitors in RA, and directions for future research. Keywords: evobrutinib, spebrutinib, acalabrutinib, fenebrutinib, rheumatoid arthritis, Bruton's tyrosine kinase
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.